Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-12 08:00 am Sale | 2025-09-30 | 13G | Anteris Technologies Global Corp. AVR | Sio Capital Management LLC | 1,772,601 4.920% | -1,161,426 (-39.58%) | Filing History |
| 2025-11-12 08:00 am Sale | 2025-09-30 | 13G | Aprea Therapeutics, Inc. APRE | Sio Capital Management LLC | 112,223 1.930% | -167,146 (-59.83%) | Filing History |
| 2025-11-12 08:00 am Sale | 2025-09-30 | 13G | Bright Minds Biosciences Inc. DRUG | Sio Capital Management LLC | 190,764 2.690% | -321,574 (-62.77%) | Filing History |
| 2025-11-12 08:00 am Sale | 2025-09-30 | 13G | NeuroOne Medical Technologies Corporation NMTC | Sio Capital Management LLC | 2,360,635 4.720% | -1,163,028 (-33.01%) | Filing History |
| 2025-11-12 08:00 am Sale | 2025-09-30 | 13G | PMV Pharmaceuticals, Inc. PMVP | Sio Capital Management LLC | 2,636,548 4.980% | -1,098,848 (-29.42%) | Filing History |
| 2025-08-13 2:00 pm Purchase | 2025-06-30 | 13G | Aligos Therapeutics, Inc. ALGS | Sio Capital Management LLC | 355,937 5.490% | 355,937 (New Position) | Filing History |
| 2025-08-13 2:00 pm Sale | 2025-06-30 | 13G | Anteris Technologies Global Corp. AVR | Sio Capital Management LLC | 2,934,027 8.140% | -530,938 (-15.32%) | Filing History |
| 2025-08-13 2:00 pm Purchase | 2025-06-30 | 13G | Aprea Therapeutics, Inc. APRE | Sio Capital Management LLC | 279,369 5.050% | 2,766 (+1.00%) | Filing History |
| 2025-08-13 2:00 pm Unchanged | 2025-06-30 | 13G | PMV Pharmaceuticals, Inc. PMVP | Sio Capital Management LLC | 3,735,396 7.190% | 0 (Unchanged) | Filing History |
| 2025-08-13 2:00 pm Purchase | 2025-06-30 | 13G | Bright Minds Biosciences Inc. DRUG | Sio Capital Management LLC | 512,338 7.270% | 4,776 (+0.94%) | Filing History |
| 2025-08-13 2:00 pm Purchase | 2025-06-30 | 13G | NeuroOne Medical Technologies Corporation NMTC | Sio Capital Management LLC | 3,523,663 7.070% | 3,523,663 (New Position) | Filing History |
| 2025-04-08 3:14 pm Sale | 2025-03-31 | 13G | Anteris Technologies Global Corp. AVR | Sio Capital Management LLC | 3,464,965 9.620% | -40 (-0.00%) | Filing History |
| 2025-04-08 3:14 pm Sale | 2025-03-31 | 13G | Aprea Therapeutics, Inc. APRE | Sio Capital Management LLC | 276,603 5.040% | -3,397 (-1.21%) | Filing History |
| 2025-04-08 3:14 pm Purchase | 2025-03-31 | 13G | Bright Minds Biosciences Inc. DRUG | Sio Capital Management LLC | 507,562 7.210% | 55,769 (+12.34%) | Filing History |
| 2025-04-08 3:14 pm Purchase | 2025-03-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | Sio Capital Management LLC | 3,735,396 7.190% | 163,229 (+4.57%) | Filing History |
| 2025-04-08 3:14 pm Sale | 2025-03-31 | 13G | Q32 Bio Inc. QTTB | Sio Capital Management LLC | 0 0.000% | -697,413 (Position Closed) | Filing History |
| 2025-04-08 3:14 pm Sale | 2025-03-31 | 13G | Vaxart, Inc. VXRT | Sio Capital Management LLC | 5,583,448 2.450% | -5,931,867 (-51.51%) | Filing History |
| 2025-04-08 3:14 pm Sale | 2025-03-31 | 13G | Ventyx Biosciences, Inc. VTYX | Sio Capital Management LLC | 2,582,655 3.630% | -1,464,142 (-36.18%) | Filing History |
| 2025-02-10 12:59 pm Purchase | 2024-12-31 | 13G | Ventyx Biosciences, Inc. VTYX | Sio Capital Management LLC | 4,046,797 5.720% | 4,046,797 (New Position) | Filing History |
| 2025-02-10 12:58 pm Purchase | 2024-12-31 | 13G | Vaxart, Inc. VXRT | Sio Capital Management LLC | 11,515,315 5.060% | 11,515,315 (New Position) | Filing History |